• Questions
  • Tournaments
  • Services
  • News
  • Questions
  • Tournaments
  • Questions
  • Questions
Feed Home
👥
Communities
💎
Metaculus Cup
🤖
Q2 AI Benchmarking
🌍
USAID Outlook
🏛️
POTUS Predictions
💵
Fiscal Showdown
Topics
✨🔝
Top Questions
🐦🦠
H5N1 Bird Flu
🕊️🌐
Global Elections
⏳🌀
5 Years After AGI
🇮🇱🇵🇸
Gaza Conflict
🦠🩺
Mpox outbreak
🇺🇦⚔️
Ukraine Conflict
categories
🤖
Artificial Intelligence
🧬
Health & Pandemics
🌎
Environment & Climate
☣️
Nuclear Technology & Risks
See all categories
  • About
  • API
  • FAQ
  • forecasting resources
  • For Journalists
  • Contact
  • Careers
GuidelinesPrivacy PolicyTerms of Use
ForbesScientific AmericanTimeVoxYale NewsNature

Will tirzepatide be approved for the treatment of obesity by the FDA or EMA before 2025?

resultYes

The Promise and Impact of the Next Generation of Weight Loss Drugs

19
1 comment1
Metaculus Journal Archives

Will 10% or more of the top 20 biggest companies in early 2023 still be in the top 20 in 2050?

58%chance